Patients with Encapsulating Peritoneal Sclerosis Have Increased Peritoneal Expression of Connective Tissue Growth Factor (CCN2), Transforming Growth Factor-β1, and Vascular Endothelial Growth Factor

INTRODUCTION: Encapsulating peritoneal sclerosis (EPS) is a devastating complication of peritoneal dialysis (PD). The pathogenesis is not exactly known and no preventive strategy or targeted medical therapy is available. CCN2 has both pro-fibrotic and pro-angiogenic actions and appears an attractive...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:PLoS One
Auteurs principaux: Abrahams, Alferso C., Habib, Sayed M., Dendooven, Amélie, Riser, Bruce L., van der Veer, Jan Willem, Toorop, Raechel J., Betjes, Michiel G. H., Verhaar, Marianne C., Watson, Christopher J. E., Nguyen, Tri Q., Boer, Walther H.
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2014
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4226475/
https://ncbi.nlm.nih.gov/pubmed/25384022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0112050
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires